In pancreatic cancer, lack of antigenicity and abundant immunosuppressive mechanisms, such as a low degree of mutation, high PD-L1 expression, and low MHC-1 expression, were reported [3, 4]. This evidence concerns the gene CD274 and familial pancreatic carcinoma.